Literature DB >> 34870583

Sleep-disordered breathing in school-aged children with Prader-Willi syndrome.

Jennifer Schaefer1, Margot J Davey1,2, Gillian M Nixon1,2.   

Abstract

STUDY
OBJECTIVES: Studies of sleep-disordered breathing (SDB) in children with Prader-Willi syndrome (PWS) have focused on early childhood and growth hormone (GH)-naïve children, but little is known about older children, including those on long-term GH therapy. This study aimed to describe the nature and prevalence of SDB in school-aged children with PWS in the growth hormone era.
METHODS: This retrospective single-center chart review included children aged 6-18 years with PWS who had overnight polysomnography not involving respiratory support over 5 years (2012-2017). The main outcome measures were the presence of obstructive sleep apnea, central sleep apnea, or hypoventilation defined by an elevated transcutaneous partial pressure of carbon dioxide (TcPCO2) as per standard pediatric criteria.
RESULTS: Seventeen children (8 males; median age 11.6 years, range 6.6-16.1 years) were included. Fifteen demonstrated SDB of different types: central sleep apnea (18%), obstructive sleep apnea (24%), both obstructive and central sleep apnea (29%), or hypoventilation without obstructive or central sleep apnea (18%). Twelve (71%) children had evidence of hypoventilation. Those with hypoventilation had a higher central apnea-hypopnea index but no difference in the obstructive apnea-hypopnea index, age, sex, growth parameters, or the presence of scoliosis or sleep-related symptoms compared with those without hypoventilation.
CONCLUSIONS: Sleep-related hypoventilation is common in school-aged children with PWS. The presence of central sleep apnea, including the quantification of central hypopneas, but not obstructive sleep apnea or clinical factors, predicted the presence of hypoventilation. Long-term polysomnography surveillance in children with PWS should include identification of central hypopneas and measurement of continuous pCO2. CITATION: Schaefer J, Davey MJ, Nixon GM. Sleep-disordered breathing in school-aged children with Prader-Willi syndrome. J Clin Sleep Med. 2022;18(4):1055-1061.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  central sleep apnea; hypoventilation; obstructive sleep apnea; polysomnography

Mesh:

Year:  2022        PMID: 34870583      PMCID: PMC8974376          DOI: 10.5664/jcsm.9788

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  35 in total

1.  The effect of growth hormone on sleep-related cardio-respiratory control in Prader-Willi syndrome.

Authors:  M Katz-Salamon; A C Lindgren; G Cohen
Journal:  Acta Paediatr       Date:  2012-03-24       Impact factor: 2.299

2.  Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Authors:  Maria E Craig; Christopher T Cowell; Pontus Larsson; William B Zipf; Edward O Reiter; Kerstin Albertsson Wikland; Michael B Ranke; David A Price
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

3.  Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment.

Authors:  T Nagai; K Obata; H Tonoki; S Temma; N Murakami; Y Katada; A Yoshino; S Sakazume; E Takahashi; R Sakuta; N Niikawa
Journal:  Am J Med Genet A       Date:  2005-07-01       Impact factor: 2.802

4.  The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.

Authors:  Paolo Marzullo; Claudio Marcassa; Riccardo Campini; Ermanno Eleuteri; Alessandro Minocci; Lorenzo Priano; Pierluigi Temporelli; Alessandro Sartorio; Roberto Vettor; Antonio Liuzzi; Graziano Grugni
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

5.  Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children.

Authors:  Jenny Berini; Valeria Spica Russotto; Paolo Castelnuovo; Stefania Di Candia; Luigi Gargantini; Graziano Grugni; Lorenzo Iughetti; Luigi Nespoli; Luana Nosetti; Giovanni Padoan; Alba Pilotta; Giuliana Trifirò; Giuseppe Chiumello; Alessandro Salvatoni
Journal:  J Clin Endocrinol Metab       Date:  2013-07-26       Impact factor: 5.958

6.  Central sleep-disordered breathing and the effects of oxygen therapy in infants with Prader-Willi syndrome.

Authors:  D S Urquhart; T Gulliver; G Williams; M A Harris; O Nyunt; S Suresh
Journal:  Arch Dis Child       Date:  2013-06-12       Impact factor: 3.791

7.  Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition.

Authors:  Korwyn Williams; Ann Scheimann; Vernon Sutton; Elizabeth Hayslett; Daniel G Glaze
Journal:  J Clin Sleep Med       Date:  2008-04-15       Impact factor: 4.062

8.  Hypoventilation disproportionate to OSAS severity in children with Prader-Willi syndrome.

Authors:  Francois Abel; Hui-Leng Tan; Valentina Negro; Nicola Bridges; Thomas Carlisle; Elaine Chan; Aidan Laverty; Michael Miligkos; Martin Samuels; Athanasios G Kaditis
Journal:  Arch Dis Child       Date:  2018-07-14       Impact factor: 3.791

9.  Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy.

Authors:  Suhail Al-Saleh; Amal Al-Naimi; Jill Hamilton; Allison Zweerink; Andrea Iaboni; Indra Narang
Journal:  J Pediatr       Date:  2012-09-02       Impact factor: 4.406

10.  Sleep disordered breathing in patients with Prader-Willi syndrome: A multicenter study.

Authors:  Martino Pavone; Valeria Caldarelli; Sonia Khirani; Marina Colella; Adriana Ramirez; Guillaume Aubertin; Antonino Crinò; Frédéric Brioude; Frédérique Gastaud; Nicole Beydon; Michèle Boulé; Lisa Giovannini-Chami; Renato Cutrera; Brigitte Fauroux
Journal:  Pediatr Pulmonol       Date:  2015-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.